The deadliest cases of COVID-19 often arise in patients with a variety of pre-existing conditions, known to medicine as “comorbidity.” A Morgridge Institute for Research project will investigate those disease relationships in the search for new drug treatments.
Author: Brian Mattmiller
Morgridge Institute Board names new chair, welcomes three new trustees
The Morgridge Institute for Research Board of Trustees voted on Wednesday to elect Carl Gulbrandsen, emeritus managing director of the Wisconsin Alumni Research Association (WARF), as the new chairman of the 20-member Morgridge Institute board.
Using nanobodies to fish for coronavirus clues
A Morgridge Institute for Research project intended to shed light on planarians — remarkable flatworms capable of almost limitless regeneration — is being repurposed to focus on the novel coronavirus causing COVID-19.
Chronicling pandemic science in real time
Morgridge virology investigator Anthony Gitter, an assistant professor of biostatistics and medical informatics at UW–Madison, has co-developed a software tool called Manubot to help orchestrate a rapid expert assessment of COVID-19 diagnostics and therapeutics.
COVID-19: A wake-up call for the need for new antiviral weapons
Given the death toll and multi-trillion dollar costs of COVID-19, it’s not hyperbole to suggest that an effort on the scale of the Space Race is needed to break the cycle of viral pandemics.